Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
Isit? Is It a People Thing?
We have really great scientists. We have, for many years, a cutting edge people doing cutting edge science. And and the same with intellectual property. It really is key. But again, i think that hiberd model that we've talked about allows us to explore more broadly than typically we could for accompany our size by the resourcing assistance of some of those other big parties that were partners with,. right? Yes. Very exciting. What else? What haven't i ask you, craig, that the you think as is is is germain or irrelevant to the story at silence right now?! You know, it's going to be really exciting for this company, as we are emerging from
Transcript
Play full episode
